BSE filing, NSE: SABRIMALA. Summary written from the filing by ALFA Finder's alert engine.
Sabrimala Industries India Ltd: key numbers
- Share price
- ₹24.59
- Market cap
- ₹21.43 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.33 Cr
- P/E (TTM)
- 69.0×Sector 41.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sabrimala Industries India Ltd
All →Sabrimala Industries India Management Change
Sabrimala Industries appointed Mr. Ankit Tiwari as Chief Financial Officer and Key Managerial Personnel, effective October 27, 2026. The board approved the appointment on the recommendation of the NRC and Audit Committee.
Sabrimala Industries India Capital Structure Change
Vivek Raheja and PACs sold 2,00,000 equity shares (2.29%) of Sabrimala Industries in the open market. This reduces their aggregate shareholding to 4.18%.
Sabrimala Industries India Annual General Meeting
Sabrimala Industries India Limited held its 42nd Annual General Meeting on September 15, 2026, through video conferencing to conduct business as per the notice.
Sabrimala Industries India Management Change
Sabrimala Industries clarified that Ms. Sangeeta Harpalani is appointed as an Additional Director (Executive) but not as the Company's CFO.
Sabrimala Industries India Other Announcement
Sabrimala Industries has issued a letter to shareholders with unregistered email IDs, providing the web-link and path to access the Annual Report for FY 2025-26.
Sabrimala Industries India Annual Report
Sabrimala Industries India Limited has submitted its Integrated Annual Report for FY 2025-26. The company's 42nd Annual General Meeting is scheduled for September 15, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.